Erin Colgan

Insider Reports History

Entity
Individual
Location
C/O Sensei Biotherapeutcs, Inc., 1405 Research Blvd., Ste. 125, Rockville, MD
Signature
/s/ Mark Ballantyne, Attorney-in-Fact
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by Erin Colgan:

Stock Role Class Num Shares Value Price $ Report Date Ownership
Sensei Biotherapeutics, Inc. CHIEF FINANCIAL OFFICER Common Stock 67.5K $53.3K $0.79 Feb 15, 2024 Direct
Sensei Biotherapeutics, Inc. CHIEF FINANCIAL OFFICER Stock Option (Right to Buy) 94.1K Feb 15, 2024 Direct

Insider Reports Filed by Erin Colgan

Symbol Company Period Transactions Value $ Form Type Date Filed Role
SNSE Sensei Biotherapeutics, Inc. Feb 15, 2024 3 -$2.87K 4 Feb 16, 2024 CHIEF FINANCIAL OFFICER
SNSE Sensei Biotherapeutics, Inc. Feb 15, 2023 1 -$16.4K 4 Sep 11, 2023 Chief Financial Officer
SNSE Sensei Biotherapeutics, Inc. Feb 15, 2023 3 $0 4/A Mar 29, 2023 Chief Financial Officer
SNSE Sensei Biotherapeutics, Inc. Feb 15, 2022 2 $0 4 Feb 17, 2022 Chief Financial Officer